OPTIMIZING BIOPSY PRECISION

TO ACHIEVE BETTER OUTCOMES

Triopsy™ advances prostate biopsy by improving how tissue is captured, mapped, and interpreted—supporting urologists, pathologists, and histologists with longer, intact samples and clearer anatomical insight. The result is more confident diagnoses, earlier treatment decisions, and better outcomes for patients.

RESERVE A WEBINAR
SCHEDULE A DEMO

By working together as an integrated biopsy system, the Triopsy™ Biopsy System delivers more representative tissue samples for more accurate diagnosis, reduces fragmentation and misclassification, and streamlines prostate biopsy workflows to save time and lower overall costs—supporting better decisions for clinicians and patients alike.

Discover How the Triopsy™ Biopsy System Makes Precision Possible

Close-up of a green pill with rounded edges and no visible markings.
Close-up of a white drone with a blue background, showing two small yellow drone parts attached to a red line.

Triopsy™ Needle

High-yield, precise needle for transrectal and transperineal biopsies.

View Product Details →

Close-up of a label maker with a tape cartridge and a handheld electronic device on a white surface.

Triopsy™ Actuator

Enables controlled, repeatable biopsy depth for consistent sampling.

View Product Details →

A white ru-loss meter with a sliding switch for selecting 2 or 4 fold settings, and a ruler for measuring the length in inches, marked with 5 cuts and 4 cuts.

Specimen Transport (IPS™)

Maintains sample orientation and integrity from procedure to lab.

View Product Details →

Medical report showing patient information, clinical history, and prostate biopsy map.

Renaissance LIS Software

Connects specimens to a secure cloud-based workflow.

View Product Details →

Colorful, circular logo with overlapping curved shapes in teal, blue, and green, with the letters 'TM' at the bottom right.

New Approach

A Connected Pathway for Better Diagnostics

The Triopsy™ advanced technology starts with prostate cancer but is designed to expand to all biopsy-accessible sites.

Meet the Experts Behind Triopsy™

Delivering better patient care through smarter, data-driven workflows

Meet the Team

Brad J. Buscher

Brad Buscher Headshot

Merchant banker guiding development, FDA processes, and capital strategies.

CEO & Executive Chairman of the Board

Paul Arangua

Paul Arangua Headshot

Epidemiologist advancing precision diagnostics and prostate biopsy technologies.

Director of Research & Product Development

Gary Heath

Gary Heath Headshot

President & Director of Engineering

 45+ years of medical device leadership and innovative engineering expertise.

Josh Cohen

Josh Cohen Headshot

 Healthcare strategist driving early-stage commercialization and go-to-market planning.

Sales & Marketing Consultant

Randy Whitaker

Portrait of a middle-aged man in a navy blazer and light blue shirt, smiling against a plain white background with a stylized blue graphic overlay.

Financial strategist with 30+ years in corporate and start-up business development.

Chief Financial Officer

John Mann

A man with dark hair and a beard, wearing a dark jacket over a light blue shirt, standing with arms crossed against a plain white background.

Regulatory Affairs & Quality Assurance Consultant

Financial strategist with 30+ years in corporate and start-up business development.

LET’S IMPROVE OUTCOMES TOGETHER

Contact the Triopsy™ team to see how our technology is optimizing cancer diagnosis for patients and clinicians.

SCHEDULE A DEMO
RESERVE A WEBINAR